Related Experiment Video
Updated: Jun 30, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026)
Insights
The Second Universal Definition of Heart Failure standardizes terminology for heart failure (HF) and its stages. This aims to improve global prevention, diagnosis, and management of HF for better patient outcomes.
Area of Science:
- Cardiology
- Public Health
Background:
- Heart failure (HF) prevalence is rising globally, complicated by ambiguous definitions hindering research and prevention.
- Standardizing HF definitions is crucial for global surveillance, diagnosis, and management.
- The 2021 consensus introduced Stage B (pre-HF) to identify at-risk individuals.
Purpose of the Study:
- To present the Second Universal Definition of Heart Failure, standardizing terminology and approach.
- To facilitate a uniform framework for clinicians, researchers, health systems, and policymakers.
- To improve global prevention, early detection, and management of heart failure.
Main Methods:
- A consensus document developed by cardiac societies and foundations.
- Revision of HF classification based on clinical realities, moving beyond rigid ejection fraction cutoffs.
- Inclusion of HF phenotypes (reduced, preserved, improved ejection fraction), causes, dynamic trajectories (improvement, remission, recovery), and social determinants.
Main Results:
- A new classification system for HF phenotypes (reduced, preserved, improved ejection fraction).
- A universal classification of HF causes is proposed.
- Acknowledgement of dynamic HF trajectories and the impact of social determinants and geographic variations on HF risk and outcomes.
Conclusions:
- The Second Universal Definition of Heart Failure provides a comprehensive, standardized framework.
- This standardization aims to enhance prevention, early detection, and management of HF worldwide.
- The ultimate goal is to improve patient care and advance global cardiovascular health.
Abstract:
Heart failure (HF) remains a pressing health concern, with rising prevalence globally. Subjectivity and ambiguity in the definition of HF and its antecedent stages have limited research, global surveillance, and prevention programs. To address this, several cardiac societies and foundations convened to standardize the definition of HF in 2021 and designated stage B or pre-HF to identify individuals at risk of developing HF. In subsequent years, substantial progress and changes have been made in aspects of preventing HF, improving HF diagnosis and management, and recognizing the importance of the affected individual's voice. Global differences and disparities in HF are better understood, as are causes and comorbidities leading to differences in care, which are also influenced by access to care. This consensus document presents the Second Universal Definition of Heart Failure, aiming to standardize terminology and facilitate a uniform approach for clinicians, researchers, health systems, and policymakers. In this definition, the classification of HF phenotypes moves away from rigid left ventricular ejection fraction cutoffs, instead grouping HF into reduced, preserved, and improved ejection fraction categories to better reflect clinical realities. A universal classification of HF causes is also proposed. The document also addresses the dynamic trajectories of HF-improvement, remission, and recovery-and highlights the impact of social determinants and geographic variation on HF risk and outcomes. By providing a comprehensive, standardized framework for HF definition and classification, this document seeks to improve prevention, early detection, and management of HF worldwide, ultimately enhancing patient care and advancing global cardiovascular health.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Heart Failure V: Medical Management
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure VI: Adjunct Therapies
